Methylprednisolone

• Rheumatoid Arthritis
• Multiple Sclerosis
• Lupus
• Asthma Exacerbations
• Inflammatory Bowel Disease

Methylprednisolone is a potent synthetic glucocorticoid with strong anti-inflammatory and immunosuppressive properties. Available in oral and injectable forms, it is used to treat a wide range of inflammatory and autoimmune conditions.

Mechanism of Action

Methylprednisolone exerts its effects through multiple mechanisms:

• Genomic effects: Binds to intracellular glucocorticoid receptors, which then translocate to the nucleus and modify gene transcription, suppressing pro-inflammatory genes and enhancing anti-inflammatory genes
• Non-genomic effects: Rapid membrane-mediated effects on cellular function
• Immunosuppression: Reduces lymphocyte proliferation, inhibits cytokine production, and decreases antibody synthesis
• Anti-inflammatory: Inhibits phospholipase A2, reducing prostaglandin and leukotriene synthesis

Available Formulations

Oral:

• Tablets: 4 mg, 8 mg, 16 mg, 32 mg
• Dose pack (Medrol Dosepak): 21 tablets of 4 mg in tapering regimen

Injectable (Methylprednisolone sodium succinate - Solu-Medrol):

• 40 mg, 125 mg, 500 mg, 1000 mg, 2000 mg vials

Injectable (Methylprednisolone acetate - Depo-Medrol):

• 20 mg/mL, 40 mg/mL, 80 mg/mL for intramuscular or intra-articular injection

Medical Uses

FDA-Approved Indications include:

• Inflammatory conditions (rheumatoid arthritis, lupus, inflammatory bowel disease)
• Allergic conditions (severe allergic reactions, asthma exacerbations)
• Dermatologic diseases (severe psoriasis, pemphigus)
• Hematologic disorders (autoimmune hemolytic anemia, ITP)
• Neurologic conditions (multiple sclerosis exacerbations)
• Transplant rejection prophylaxis
• Adrenal insufficiency (replacement therapy)

High-dose IV methylprednisolone ("pulse therapy") is commonly used for acute MS relapses and severe autoimmune flares.

Dosing Guidelines

Anti-inflammatory/Immunosuppressive (Oral):

• Initial: 4-48 mg daily depending on condition
• Adjust based on response
• Taper gradually when discontinuing after prolonged use

Acute MS Exacerbation:

• 1000 mg IV daily for 3-5 days
• May be followed by oral prednisone taper

Acute Spinal Cord Injury (controversial):

• High-dose protocol: 30 mg/kg IV bolus, then 5.4 mg/kg/hour infusion

Joint Injections:

• Small joints: 4-10 mg
• Large joints: 20-80 mg

Important Safety Information

Contraindications:

• Systemic fungal infections
• Known hypersensitivity to methylprednisolone

Warnings and Precautions:

• Adrenal suppression with chronic use (do not stop abruptly)
• Increased infection risk and masking of infections
• Psychiatric disturbances (euphoria, insomnia, mood swings, psychosis)
• Hyperglycemia and diabetes exacerbation
• Osteoporosis with long-term use
• Peptic ulcer disease
• Hypertension and fluid retention
• Growth suppression in children
• Cataracts and glaucoma

Drug Interactions

• CYP3A4 inducers (phenytoin, rifampin): Decrease methylprednisolone levels
• CYP3A4 inhibitors (ketoconazole, erythromycin): Increase methylprednisolone levels
• NSAIDs: Increased GI bleeding risk
• Warfarin: Variable effects on anticoagulation
• Live vaccines: Contraindicated during immunosuppressive therapy
• Antidiabetic agents: May require dose adjustments

Special Populations

• Pregnancy: Use only if benefit outweighs risk; may cause fetal adrenal suppression
• Lactation: Enters breast milk; weigh benefits and risks
• Pediatric: Use lowest effective dose; monitor growth
• Elderly: Increased risk of osteoporosis, hypertension, diabetes